IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 24.158
NA - Nord America 11.066
EU - Europa 4.604
SA - Sud America 1.903
AF - Africa 234
OC - Oceania 74
AN - Antartide 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 42.044
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 15.418
US - Stati Uniti d'America 10.547
CN - Cina 3.691
HK - Hong Kong 3.009
IT - Italia 2.121
BR - Brasile 1.407
GB - Regno Unito 808
VN - Vietnam 779
FR - Francia 651
IN - India 308
DE - Germania 291
CA - Canada 258
BD - Bangladesh 235
AR - Argentina 213
MX - Messico 164
ID - Indonesia 121
NL - Olanda 107
ZA - Sudafrica 96
TR - Turchia 84
JP - Giappone 79
FI - Finlandia 75
EC - Ecuador 72
UA - Ucraina 72
AU - Australia 67
PL - Polonia 63
RU - Federazione Russa 60
CO - Colombia 55
SA - Arabia Saudita 54
ES - Italia 52
IQ - Iraq 51
PY - Paraguay 50
PK - Pakistan 36
SE - Svezia 36
CL - Cile 35
CZ - Repubblica Ceca 35
UZ - Uzbekistan 32
MD - Moldavia 31
PH - Filippine 31
PE - Perù 30
MA - Marocco 25
MY - Malesia 23
VE - Venezuela 22
EG - Egitto 21
BE - Belgio 19
CH - Svizzera 19
JM - Giamaica 19
EE - Estonia 18
LT - Lituania 18
NP - Nepal 18
AZ - Azerbaigian 16
KR - Corea 16
CR - Costa Rica 14
DZ - Algeria 14
UY - Uruguay 14
ET - Etiopia 13
DO - Repubblica Dominicana 12
KZ - Kazakistan 12
TH - Thailandia 12
AT - Austria 11
IL - Israele 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
BH - Bahrain 10
KE - Kenya 10
RO - Romania 10
SI - Slovenia 10
TW - Taiwan 10
GR - Grecia 9
HN - Honduras 9
OM - Oman 9
PT - Portogallo 9
AL - Albania 8
BA - Bosnia-Erzegovina 8
GT - Guatemala 8
HU - Ungheria 8
IE - Irlanda 8
JO - Giordania 8
KG - Kirghizistan 8
PS - Palestinian Territory 8
KH - Cambogia 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
SY - Repubblica araba siriana 7
BY - Bielorussia 6
CY - Cipro 6
KW - Kuwait 6
NI - Nicaragua 6
SV - El Salvador 6
DK - Danimarca 5
LB - Libano 5
AM - Armenia 4
BG - Bulgaria 4
BO - Bolivia 4
DM - Dominica 4
GA - Gabon 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
MN - Mongolia 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
Totale 41.950
Salva come PNG Salva come JPEG
Città #
San Jose 3.873
Hong Kong 2.987
Ashburn 2.523
Singapore 2.348
Rome 1.629
Hefei 1.390
Boardman 801
Beijing 720
London 673
Lauterbourg 593
Shanghai 488
Dallas 459
Ho Chi Minh City 260
Los Angeles 188
Hanoi 177
New York 176
San Francisco 166
Council Bluffs 151
Santa Clara 150
São Paulo 137
Pune 106
Seattle 106
Toronto 106
Munich 95
Mexico City 92
Washington 66
Tokyo 61
Warsaw 54
Rio de Janeiro 52
Amsterdam 51
Orem 48
Johannesburg 43
Brooklyn 42
Montreal 41
Chennai 40
Frankfurt am Main 40
Turku 40
Chicago 36
Helsinki 35
Haiphong 34
Melbourne 33
Milan 32
Da Nang 31
Tashkent 30
Brno 29
Belo Horizonte 28
Thái Bình 28
Biên Hòa 27
Boston 27
Stockholm 27
Naples 26
Riyadh 25
Atlanta 24
Phoenix 24
Buenos Aires 23
Hangzhou 23
Quito 23
Asunción 22
Baghdad 21
Guayaquil 21
Manchester 21
New Delhi 21
Jeddah 20
Ribeirão Preto 20
Secaucus 20
Brasília 19
Curitiba 19
Lima 19
Campinas 17
Bogotá 16
Canberra 16
Charlotte 16
Jakarta 16
Ninh Bình 16
Sydney 16
West Jordan 16
Ankara 15
Kingston 15
Porto Alegre 15
Guangzhou 14
Istanbul 14
San José 14
St Louis 14
Addis Ababa 13
Bologna 13
Buffalo 13
Hyderabad 13
Las Vegas 13
Manaus 13
Mumbai 13
Paris 13
Salvador 13
Baku 12
Caxias do Sul 12
Denver 12
Goiânia 12
Hanover 12
Hasselt 12
Palermo 12
Bắc Giang 11
Totale 22.202
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 272
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 257
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 256
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 248
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 246
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 238
Early impairment of food intake in patients newly diagnosed with cancer 235
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 235
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 234
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 233
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 232
Designing a broad-spectrum integrative approach for cancer prevention and treatment 232
A key opinion leader interview with Prof D Santini: insight into cancer research. 231
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 230
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 229
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 228
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 223
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 221
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 219
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 218
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 218
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 217
Prevention of radiotherapy-induced emesis 216
Premetastatic niche: ready for new therapeutic interventions? 215
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 214
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 213
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 213
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 213
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 212
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 212
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 211
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 210
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 204
Docetaxel induced pericardial effusion 204
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 201
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 200
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 198
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 194
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 191
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 177
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 167
A giant sarcoma of the parotid gland: A case report and review of the literature 162
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 154
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 152
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 146
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 146
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 139
'Old' and 'new' drugs for the treatment of cancer pain 139
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 138
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 138
Anestesia e malattie non comuni 137
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 135
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 135
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 134
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 134
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 132
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 131
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 131
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 130
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 129
Colorectal carcinomas and PTEN/MMAC1 gene mutations 127
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 127
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 125
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 125
Biological effects of cabozantinib on bone microenvironment 125
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 125
[Treatment of stage-I seminoma. Critical review] 124
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 124
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 123
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 123
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 122
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 121
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 121
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 119
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 117
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 117
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 116
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 115
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 115
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 114
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 114
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 114
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 113
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 111
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 111
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 111
Idiosyncratic reaction after oxaliplatin infusion 110
Atypical chronic head and neck pain: don't forget Eagle's syndrome 110
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature 109
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 104
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 104
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 104
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 101
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 100
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 100
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 98
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 96
Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study 94
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 93
A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients 92
Totale 16.173
Salva come PNG Salva come JPEG
Categoria #
all - tutte 334.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 334.869
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.008 0 4 5 8 73 10 15 4 42 20 23 804
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.295 52 281 95 171 237 1.039 17 154 23 59 75 92
2024/202518.553 334 274 922 147 171 510 314 63 1.954 1.573 5.751 6.540
2025/202620.120 1.870 776 1.374 2.466 701 1.230 5.302 1.801 1.703 1.872 816 209
Totale 42.179